The area of depigmentation shows no clinical signs of inflammation and, even though it may persist for many months and even years, it ultimately repigments in most cases
Retrieved from Wilkinson, J
Preliminary research and patient anecdotes indicate GLP-1s can assist with weight management in people with lipedema
This is counterproductive
In the UK, the pathway to approval typically involves: Submission of a Marketing Authorisation Application (MAA) to the MHRA Scientific review of clinical trial data, including safety, efficacy, and quality data Benefit-risk assessment by MHRA experts If approved, a subsequent NICE technology appraisal to determine whether the medicine represents value for money and should be made available within the NHS The MHRA also operates an Early Access to Medicines Scheme (EAMS) , which can allow patients with life-threatening or seriously debilitating conditions to access promising unlicensed medicines before full approval
Any website or pharmacy claiming to sell generic semaglutide before patent expiration is likely selling counterfeit or unauthorized products